
Boson Remedies Private Limited
About Boson Remedies Private Limited
Data last updated:
Boson Remedies Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U33110UP2010PTC041224. Its GSTIN is 09AAECB1633M1ZL (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Uma Sharma and Hemant Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 13 Ram Kishan Kunj Colony Sahibabad, Ghaziabad, Uttar Pradesh, India – 201005.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Boson Remedies Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address13 Ram Kishan Kunj Colony Sahibabad, Ghaziabad, Uttar Pradesh, India – 201005
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Boson Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Boson Remedies Private Limited
FY 2025 filings availableBoson Remedies Private Limited reported revenue of ₹203 (down 100% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 86% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Boson Remedies Private Limited, buy the company report.
Board of directors of Boson Remedies Private Limited
Boson Remedies has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uma Sharma Also directs: Cura Ayurvedic & Unani Limited | Director | 01 Jul 2010 | 16 Years 4 Months | Current |
| Hemant Kumar Sharma Also directs: Cura Ayurvedic & Unani Limited, Cura Foods Private Limited | Director | 01 Jul 2010 | 16 Years 4 Months | Current |
| Himanshu Hemant Also directs: Cura Ayurvedic & Unani Limited | Director | 08 Jan 2016 | 10 Years 10 Months | Current |
Auditor
Boson Remedies Private Limited is audited by GARG & AGARWAL for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARG & AGARWAL | FY 2018 | 020073N |
Shareholding
The shareholding of Boson Remedies Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Boson Remedies Private Limited, buy the company report.
Legal cases
Boson Remedies Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nagpur, Maharashtra | Court case (R.C.C.) | Filed against the company by State of Maharashtra | Pending |
To see the full case history of Boson Remedies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Boson Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Boson Remedies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECB1633M1ZL | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Boson Remedies Private Limited, buy the company report.
Recent activity
Boson Remedies Private Limited has 5 board changes on record since 2010: 4 appointments and 1 cessation. The latest: Himanshu Hemant was appointed as Director on 08 Jan 2016.
Frequently asked questions
Boson Remedies is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 July 2010 (16+ years old) and is registered under CIN U33110UP2010PTC041224.
Boson Remedies has 3 current directors:
- Uma Sharma - Director
- Hemant Kumar Sharma - Director
- Himanshu Hemant - Director
The latest financial statements of Boson Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Boson Remedies is 09AAECB1633M1ZL, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Boson Remedies is U33110UP2010PTC041224. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Boson Remedies has 1 court case on record: 1 filed against it. 1 is pending.
Boson Remedies was incorporated on 01 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kanpur.
Himanshu Hemant was appointed as Director on 08 Jan 2016. Manish Kumar ceased to be Director on 08 Jan 2016. Hemant Kumar Sharma was appointed as Director on 01 Jul 2010. Boson Remedies has 5 board changes on record in total.
The registered office of Boson Remedies is at 13 Ram Kishan Kunj Colony Sahibabad, Ghaziabad, Uttar Pradesh, India – 201005.
Boson Remedies operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

